127 related articles for article (PubMed ID: 18578862)
1. Abnormal hCG levels in a patient with treated stage I seminoma: a diagnostic dilemma.
Aherne NJ; Small CA; McVey GP; Fitzpatrick DG; Armstrong JG
World J Surg Oncol; 2008 Jun; 6():68. PubMed ID: 18578862
[TBL] [Abstract][Full Text] [Related]
2. Histologically pure stage I seminoma with an elevated beta-hCG of 4497 IU/l.
Bjurlin MA; August CZ; Weldon-Linne M; Totonchi E
Urology; 2007 Nov; 70(5):1007.e13-5. PubMed ID: 18068467
[TBL] [Abstract][Full Text] [Related]
3. Treatment of stage I seminoma: should beta-HCG positive seminoma be treated aggressively?
Suzuki K; Nakazato H; Kurokawa K; Suzuki T; Suzuki K; Yamanaka H
Int Urol Nephrol; 1998; 30(5):593-8. PubMed ID: 9934803
[TBL] [Abstract][Full Text] [Related]
4. Testicular seminoma with human chorionic gonadotropin production.
Hori K; Uematsu K; Yasoshima H; Yamada A; Sakurai K; Ohya M
Pathol Int; 1997 Sep; 47(9):592-9. PubMed ID: 9311009
[TBL] [Abstract][Full Text] [Related]
5. Significance of simultaneous determination of serum human chorionic gonadotropin (hCG) and hCG-beta in testicular tumor patients.
Hoshi S; Suzuki K; Ishidoya S; Ohyama C; Sato M; Namima T; Saito S; Orikasa S
Int J Urol; 2000 Jun; 7(6):218-23. PubMed ID: 10843453
[TBL] [Abstract][Full Text] [Related]
6. The management and clinical course of testicular seminoma: 15 years' experience at a single institution.
Coleman JM; Coleman RE; Turner AR; Radstone CR; Champion AE
Clin Oncol (R Coll Radiol); 1998; 10(4):237-41. PubMed ID: 9764375
[TBL] [Abstract][Full Text] [Related]
7. The search for biomarkers of metastatic seminoma.
Ruf CG; Khalili-Harbi N; Sachs S; Isbarn H; Wagner W; Matthies C; Meineke V; Fisch M; Chun FK; Abend M
J Urol; 2013 Sep; 190(3):1046-51. PubMed ID: 23583226
[TBL] [Abstract][Full Text] [Related]
8. Free beta-subunit of human chorionic gonadotropin in serum is a diagnostically sensitive marker of seminomatous testicular cancer.
Lempiäinen A; Stenman UH; Blomqvist C; Hotakainen K
Clin Chem; 2008 Nov; 54(11):1840-3. PubMed ID: 18787014
[TBL] [Abstract][Full Text] [Related]
9. Pitfalls of hCG monitoring in stage I seminoma.
Wylie JP; Logue JP
Clin Oncol (R Coll Radiol); 1998; 10(2):131-2. PubMed ID: 9610904
[TBL] [Abstract][Full Text] [Related]
10. Suppression of spermatogenesis in ipsilateral and contralateral testicular tissues in patients with seminoma by human chorionic gonadotropin beta subunit.
Hayashi T; Arai G; Hyochi N; Suzuki M; Masuda H; Kawakami S; Okuno T; Ishizaka K; Kageyama Y; Kihara K
Urology; 2001 Aug; 58(2):251-7. PubMed ID: 11489712
[TBL] [Abstract][Full Text] [Related]
11. Choriogonadotropin positive seminoma-a clinicopathological and molecular genetic study of 15 cases.
Hes O; Pivovarcikova K; Stehlik J; Martinek P; Vanecek T; Bauleth K; Dolejsova O; Petersson F; Hora M; Perez Montiel D; Peckova K; Branzovsky J; Slouka D; Vodicka J; Kokoskova B; Matej R; Michal M
Ann Diagn Pathol; 2014 Apr; 18(2):89-94. PubMed ID: 24480432
[TBL] [Abstract][Full Text] [Related]
12. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
13. Elevated human chorionic gonadotropin concentrations in the testicular vein and in peripheral venous blood in seminoma patients. An analysis of various parameters.
Hartmann M; Pottek T; Bussar-Maatz R; Weissbach L
Eur Urol; 1997; 31(4):408-13. PubMed ID: 9187899
[TBL] [Abstract][Full Text] [Related]
14. No predictive value of beta-hCG in patients with stage I seminoma--results of a long-term follow-up study after adjuvant radiotherapy.
Bruns F; Raub M; Schaefer U; Micke O
Anticancer Res; 2005; 25(3A):1543-6. PubMed ID: 16033057
[TBL] [Abstract][Full Text] [Related]
15. Postoperative reduction of serum beta-HCG in testicular seminoma.
Sakashita S; Demura T; Gotoh T; Maru A; Koyanagi T
Int Urol Nephrol; 1988; 20(3):281-6. PubMed ID: 2456999
[TBL] [Abstract][Full Text] [Related]
16. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
[TBL] [Abstract][Full Text] [Related]
17. Seminoma testis with elevated serum beta-HCG--a category of germ-cell cancer between seminoma and nonseminoma.
Dieckmann KP; Düe W; Bauer HW
Int Urol Nephrol; 1989; 21(2):175-84. PubMed ID: 2473044
[TBL] [Abstract][Full Text] [Related]
18. The incidence, prognosis, clinical and histological characteristics, treatment, and outcome of patients with bilateral germ cell testicular cancer in Hungary.
Géczi L; Gomez F; Bak M; Bodrogi I
J Cancer Res Clin Oncol; 2003 May; 129(5):309-15. PubMed ID: 12748851
[TBL] [Abstract][Full Text] [Related]
19. [An unusual seminoma].
Deminière C; Paradis V; Vieillefond A; Savin de Larclause AM; Morard JL
Ann Pathol; 1994; 14(2):127-8. PubMed ID: 7515236
[No Abstract] [Full Text] [Related]
20. Human Chorionic Gonadotropin Assays for Testicular Tumors: Closing the Gap between Clinical and Laboratory Practice.
Ferraro S; Trevisiol C; Gion M; Panteghini M
Clin Chem; 2018 Feb; 64(2):270-278. PubMed ID: 29021329
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]